The sociability index scores in MT-II-treated MIA mice increased dramatically from a pre-treatment baseline of 3.1 1.2 to 26.3 3.9 post-treatment, reaching levels comparable to those observed in control C57BL/6J mice
Emerging data also suggest possible roles in treating substance use disorders, including alcohol and nicotine dependence, though findings remain preliminary and variable
GLP-1 receptor agonist medications amplify these natural processes, which can lead to reduced food intake and, over time, weight loss for some individuals
The integration of microfluidic arrays and automated positioning systems (e.g., Fish-in-Capsule, ZEBRA) has substantially enhanced experimental scalability and imaging reproducibility
Ongoing monitoring to make sure the dose is correct and side effects are controlled
Inflammation from peripheral organs to the brain: how does systemic inflammation cause neuroinflammation